Skip to main content

The Impact of Pre-analytic Variables on Tissue Quality from Clinical Samples Collected in a Routine Clinical Setting: Implications for Diagnostic Evaluation, Drug Discovery, and Translational Research

  • Protocol
  • First Online:
Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development

Part of the book series: Methods in Pharmacology and Toxicology ((MIPT))

Abstract

The increasing application of biomarkers in both clinical practice and research has led to a greater emphasis on optimal sample preparation for such assays. However, in most institutions, current practices involved in tissue handling are highly variable and these variations can affect the quality of specimens used for analysis of macromolecules of potential clinical and research interest. In an attempt to address this important emerging issue, and to standardize tissue handling at our institution, the Surgical Pathology Laboratory has implemented an active tissue acquisition program in collaboration with the staff in the operating rooms and the Department of Surgery. Designated technical personnel from our laboratory assigned to the operating rooms are contacted as soon as a specimen is available. They are then responsible for collection of the specimen, checking accuracy on both the requisition and specimen label, and transportation of the specimen to the laboratory. With this implementation, we have seen significant improvements in the median time to fixation and the total number of specimens placed into formalin within 1 h of surgical removal from the patient. Rather than pushing an already busy OR staff to deliver specimens in a more timely fashion, we have found that a joint collaboration between departments, and proactively “pulling” specimens into the laboratory was more successful in achieving our goal of standardizing tissue handling and minimizing the time from surgical removal to the start of fixation. In addition, the type of tissue fixation and the time in fixative has the potential to impact the quality of tissue samples for molecular analysis of routinely collected clinical samples. These important issues will be reviewed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Hicks DG (2012) Targeted therapies in breast cancer: tailoring treatment to the molecular drivers of disease progression. MLO Med Lab Obs 44(36):38–39

    Google Scholar 

  2. Van de Vijver MJ, He YD, van’t Veer LJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009

    Article  PubMed  Google Scholar 

  3. Hicks DG, Kulkarni S, Hammond ME (2008) The role of the indispensable surgical pathologist in treatment planning for breast cancer. Arch Pathol Lab Med 132:1226–1227

    PubMed  Google Scholar 

  4. Romond EH, Perez EA, Bryant J et al (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353:1673–1684

    Article  CAS  PubMed  Google Scholar 

  5. Hicks D, Whitney-Miller C (2013) The evolving role of HER2 evaluation for diagnosis and clinical decision making for breast and gastric adenocarcinoma. Biotech Histochem 88:121–131

    Article  CAS  PubMed  Google Scholar 

  6. Parkinson B, Pearson SA, Viney R (2013) Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique. Eur J Health Econ Feb 24. [Epub ahead of print] PubMed PMID: 23436142

    Google Scholar 

  7. Barron JJ, Cziraky MJ, Weisman T, Hicks DG (2009) HER2 testing and subsequent trastuzumab treatment for breast cancer in a managed care environment. Oncologist 14:760–768

    CAS  PubMed  Google Scholar 

  8. Hicks DG, Boyce BF (2012) The challenge and importance of standardizing pre-analytical variables in surgical pathology specimens for clinical care and translational research. Biotech Histochem 87:14–17

    Article  CAS  PubMed  Google Scholar 

  9. Hicks DG, McMahon L (2010) The pros and cons of automation for immunohistochemistry from the prospective of the pathology laboratory. In: Shi S, Taylor C (eds) Immunohistochemistry & antigen retrieval technique based research & diagnostics. Wiley, Hoboken, NJ, Chapter 7

    Google Scholar 

  10. Yaziji H, Taylor CR, Goldstein NS et al (2008) Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry. Appl Immunohistochem Mol Morphol 16:513–520

    Article  CAS  PubMed  Google Scholar 

  11. Hicks DG, Kulkarni S (2008) Trastuzumab as adjuvant therapy for early breast cancer: the importance of accurate human epidermal growth factor receptor 2 testing. Arch Pathol Lab Med 132:1008–1015

    CAS  PubMed  Google Scholar 

  12. Hicks DG, Kulkarni S (2008) HER2+ breast cancer: review of biologic relevance and optimal use of diagnostic tools. Am J Clin Pathol 129:263–273

    Article  PubMed  Google Scholar 

  13. Hewitt SM, Lewis FA, Cao Y et al (2008) Tissue handling and specimen preparation in surgical pathology: issues concerning the recovery of nucleic acids from formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med 132:1929–1935

    PubMed  Google Scholar 

  14. Liu NW, Sanford T, Srinivasan R et al (2013) Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma. Clin Cancer Res 19:42–49

    Article  PubMed Central  PubMed  Google Scholar 

  15. Hicks DG, Kushner L, McCarthy K (2011) Breast cancer predictive factor testing: the challenges and importance of standardizing tissue handling. J Natl Cancer Inst Monogr 2011:43–45

    Article  PubMed  Google Scholar 

  16. Wolff AC, Hammond ME, Schwartz JN, American Society of Clinical Oncology/College of American Pathologists et al (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131:18–43

    CAS  PubMed  Google Scholar 

  17. Hammond ME, Hayes DF, Dowsett M et al (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784–2795

    Article  PubMed Central  PubMed  Google Scholar 

  18. Balch CM (2011) Reexamining our routines of handing surgical tissue in the operating room. J Natl Cancer Inst Monogr 42:39–40

    Article  Google Scholar 

  19. Sherman ME, Howatt W, Blows FM et al (2010) Molecular pathology in epidemiologic studies: a primer on key considerations. Cancer Epidemiol Biomarkers Prev 19:966–972

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Dash A, Maine IP, Varambally S et al (2002) Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens. Am J Pathol 161:1743–1748

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Miyatake Y, Ikeda H, Michimata R et al (2004) Differential modulation of gene expression among rat tissues with warm ischemia. Exp Mol Pathol 77:222–230

    Article  CAS  PubMed  Google Scholar 

  22. Cross SS, Start RD, Smith JH (1990) Does delay in fixation affect the number of mitotic figures in processed tissue? J Clin Pathol 43:597–599

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Start RD, Flynn MS, Cross SS et al (1991) Is the grading of breast carcinomas affected by a delay in fixation? Virchows Arch A Pathol Anat Histopathol 419:475–477

    Article  CAS  PubMed  Google Scholar 

  24. van Maldegem F, de Wit M, Morsink F et al (2008) Effects of processing delay, formalin fixation, and immunohistochemistry on RNA recovery from formalin-fixed paraffin-embedded tissue sections. Diagn Mol Pathol 17:51–58

    PubMed  Google Scholar 

  25. Khoury T, Sait S, Hwang H et al (2009) Delay to formalin fixation effect on breast biomarkers. Mod Pathol 22:1457–1467

    Article  CAS  PubMed  Google Scholar 

  26. Pinhel IF, MacNeill FA, Hills MJ (2010) Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer. Breast Cancer Res 12:R76

    Article  PubMed Central  PubMed  Google Scholar 

  27. Neumeister VM, Anagnostou V, Siddiqui S et al (2012) Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues. J Natl Cancer Inst 104:1815–1824

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Goldstein NS (2010) Standardized predictive receptor immunohistochemical assays: the view forward from our past. Am J Clin Pathol 133:681–683

    Article  PubMed  Google Scholar 

  29. Nkoy FL, Hammond ME, Rees W et al (2010) Variable specimen handling affects hormone receptor test results in women with breast cancer: a large multihospital retrospective study. Arch Pathol Lab Med 134:606–612

    PubMed  Google Scholar 

  30. Yildiz-Aktas IZ, Dabbs DJ, Bhargava R (2012) The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma. Mod Pathol 25:1098–1105

    Article  CAS  PubMed  Google Scholar 

  31. Kulkarni S, Hicks DG (2008) HER2-positive early breast cancer and trastuzumab: a surgeon’s perspective. Ann Surg Oncol 15:1677–1688

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The author would like to thank Ms. Mary Jackson for her assistance in manuscript preparation. The author would also like to thank and acknowledge the work of Kristin McCarthy, Robyn Sage, Laurie Baxter, and Michelle Fuller from the department of Pathology as well as the Operating Room staff for their help and support for this quality improvement project.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David G. Hicks M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this protocol

Cite this protocol

Hicks, D.G. (2014). The Impact of Pre-analytic Variables on Tissue Quality from Clinical Samples Collected in a Routine Clinical Setting: Implications for Diagnostic Evaluation, Drug Discovery, and Translational Research. In: Potts, S., Eberhard, D., Wharton, Jr., K. (eds) Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development. Methods in Pharmacology and Toxicology. Humana Press, New York, NY. https://doi.org/10.1007/7653_2014_18

Download citation

  • DOI: https://doi.org/10.1007/7653_2014_18

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-2680-0

  • Online ISBN: 978-1-4939-2681-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics